Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / SMAWF - Siemens at-home COVID test granted FDA Emergency Use Authorization


SMAWF - Siemens at-home COVID test granted FDA Emergency Use Authorization

The CLINITEST Rapid COVID-19 Antigen Self-Test from Siemens Healthineers (OTCPK:SIEGY) received Emergency Use Authorization from the FDA. The authorization is for use by individuals 14 years old and older. Adults can collect samples in children 2 years and older. Like other at-home tests, Siemens (OTCPK:SMAWF) CLINITEST uses a nasal swab. A Roche (OTCQX:RHHBY) at-home COVID test received EUA last week.

For further details see:

Siemens at-home COVID test granted FDA Emergency Use Authorization
Stock Information

Company Name: Siemens AG
Stock Symbol: SMAWF
Market: OTC

Menu

SMAWF SMAWF Quote SMAWF Short SMAWF News SMAWF Articles SMAWF Message Board
Get SMAWF Alerts

News, Short Squeeze, Breakout and More Instantly...